ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 256 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,912,851 | -24.6% | 220,054 | 0.0% | 0.04% | -26.3% |
| Q2 2023 | $7,847,126 | +16.5% | 220,054 | -23.6% | 0.06% | +21.3% |
| Q1 2023 | $6,734,384 | -53.6% | 288,054 | -19.6% | 0.05% | -52.0% |
| Q4 2022 | $14,521,990 | -1.9% | 358,054 | -20.1% | 0.10% | -5.8% |
| Q3 2022 | $14,809,000 | +10.9% | 448,054 | +18.1% | 0.10% | -5.5% |
| Q2 2022 | $13,357,000 | +7.6% | 379,365 | +40.5% | 0.11% | +29.4% |
| Q1 2022 | $12,419,000 | +216.5% | 270,054 | +356.3% | 0.08% | +240.0% |
| Q4 2021 | $3,924,000 | -68.0% | 59,187 | -69.9% | 0.02% | -69.9% |
| Q3 2021 | $12,261,000 | -24.6% | 196,408 | 0.0% | 0.08% | -25.2% |
| Q2 2021 | $16,267,000 | +34.6% | 196,408 | +19.8% | 0.11% | +9.9% |
| Q1 2021 | $12,084,000 | -4.0% | 163,958 | 0.0% | 0.10% | +1.0% |
| Q4 2020 | $12,581,000 | +7.8% | 163,958 | -39.5% | 0.10% | -9.1% |
| Q3 2020 | $11,675,000 | -15.8% | 271,146 | -15.6% | 0.11% | -24.7% |
| Q2 2020 | $13,871,000 | -20.8% | 321,146 | +13.7% | 0.15% | -24.7% |
| Q1 2020 | $17,517,000 | -2.2% | 282,508 | 0.0% | 0.19% | +1.0% |
| Q4 2019 | $17,919,000 | -18.9% | 282,508 | -64.0% | 0.19% | -34.5% |
| Q3 2019 | $22,093,000 | +58.3% | 784,000 | +48.2% | 0.29% | +68.4% |
| Q2 2019 | $13,957,000 | +28.0% | 529,000 | -10.9% | 0.17% | +25.2% |
| Q1 2019 | $10,900,000 | +47.8% | 594,000 | 0.0% | 0.14% | +23.0% |
| Q4 2018 | $7,377,000 | -25.1% | 594,000 | +15.6% | 0.11% | -13.7% |
| Q3 2018 | $9,853,000 | – | 514,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |